Literature DB >> 8625663

Severe osteoporosis before and after lung transplantation.

R M Aris1, I P Neuringer, M A Weiner, T M Egan, D Ontjes.   

Abstract

STUDY
OBJECTIVE: Osteoporosis and/or fractures have been reported as a complication of kidney, heart, liver, bone marrow, and, most recently, lung transplantation (LTx). We measured bone mineral density (BMD) before and after LTx to determine the frequency and severity of preoperative and postoperative osteoporosis. PATIENTS AND METHODS: We conducted a cross-sectional study of BMD in 100 patients with various diagnoses before (n = 55) and after (n = 45) LTx.
RESULTS: Age-matched mean spine and femoral BMDs were severely depressed before and after LTx placing 45% of the pre-LTx and 73% of the post-LTx patients at or below the fracture threshold (2 SDs below the mean). As expected, patients with cystic fibrosis had lower (p < 0.05) mean spine and femoral BMD than patients with COPD or other lung diseases both before and after LTx. Nevertheless, considerable osteoporosis was present in the patients with COPD and other lung diseases before and after LTx. The best predictors of pre- and post-LTxZ scores were body mass index (r = 0.56 to 0.59, p < 0.001) and cumulative steroid dose/per kilogram (r = 0.49-0.51, p < 0.001), respectively. Osteoporosis has resulted in 3 symptomatic fractures before and 12 after LTx.
CONCLUSIONS: Osteoporosis appears to be widespread in patients with end-stage respiratory failure before LTx and LTx, while often life-saving, has an adverse impact on BMD. As patients live longer after LTx, osteoporosis-related fractures may compromise quality of life by causing pain and debilitation.

Entities:  

Mesh:

Year:  1996        PMID: 8625663     DOI: 10.1378/chest.109.5.1176

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  22 in total

1.  Idiopathic pulmonary fibrosis a rare disease with severe bone fragility.

Authors:  Carla Caffarelli; Stefano Gonnelli; Maria Dea Tomai Pitinca; Valentina Francolini; Annalisa Fui; Elena Bargagli; Rosa Metella Refini; David Bennett; Ranuccio Nuti; Paola Rottoli
Journal:  Intern Emerg Med       Date:  2016-07-08       Impact factor: 3.397

2.  Implications of combined ovariectomy and glucocorticoid (dexamethasone) treatment on mineral, microarchitectural, biomechanical and matrix properties of rat bone.

Authors:  Parameswari Govindarajan; Thaqif Khassawna; Marian Kampschulte; Wolfgang Böcker; Britta Huerter; Lutz Dürselen; Miriam Faulenbach; Christian Heiss
Journal:  Int J Exp Pathol       Date:  2013-09-02       Impact factor: 1.925

3.  Bone mineral status in 134 patients with cystic fibrosis.

Authors:  E M Laursen; C Molgaard; K F Michaelsen; C Koch; J Müller
Journal:  Arch Dis Child       Date:  1999-09       Impact factor: 3.791

Review 4.  Lung transplantation for cystic fibrosis: results, indications, complications, and controversies.

Authors:  Joseph P Lynch; David M Sayah; John A Belperio; S Sam Weigt
Journal:  Semin Respir Crit Care Med       Date:  2015-03-31       Impact factor: 3.119

5.  Bone involvement in young adults with cystic fibrosis awaiting lung transplantation for end-stage respiratory failure.

Authors:  E Cairoli; C Eller-Vainicher; L C Morlacchi; P Tarsia; V Rossetti; M Pappalettera; M Arosio; I Chiodini; F Blasi
Journal:  Osteoporos Int       Date:  2019-02-23       Impact factor: 4.507

6.  Hypervitaminosis D: case report of pediatric osteoporosis secondary to cystic fibrosis.

Authors:  Pietro Cialdella; Francesco Carella
Journal:  Clin Cases Miner Bone Metab       Date:  2011-09

7.  Vitamin d deficiency in cystic fibrosis.

Authors:  William B Hall; Amy A Sparks; Robert M Aris
Journal:  Int J Endocrinol       Date:  2010-01-28       Impact factor: 3.257

8.  Vitamin D inhibition of pro-fibrotic effects of transforming growth factor beta1 in lung fibroblasts and epithelial cells.

Authors:  Allan M Ramirez; Cherry Wongtrakool; Teresa Welch; Andreas Steinmeyer; Ulrich Zügel; Jesse Roman
Journal:  J Steroid Biochem Mol Biol       Date:  2009-11-17       Impact factor: 4.292

9.  Effect of oral bisphosphonates on bone mineral density and body composition in adult patients with cystic fibrosis: a pilot study.

Authors:  S P Conway; B Oldroyd; A Morton; J G Truscott; D G Peckham
Journal:  Thorax       Date:  2004-08       Impact factor: 9.139

Review 10.  Management of osteoporosis in adults with cystic fibrosis.

Authors:  Travis M Hecker; Robert M Aris
Journal:  Drugs       Date:  2004       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.